Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Rheumatoid arthritis patients display B-cell dysregulation already in the naïve repertoire consistent with defects in B-cell tolerance.

Wang Y, Lloyd KA, Melas I, Zhou D, Thyagarajan R, Lindqvist J, Hansson M, Svärd A, Mathsson-Alm L, Kastbom A, Lundberg K, Klareskog L, Catrina AI, Rapecki S, Malmström V, Grönwall C.

Sci Rep. 2019 Dec 27;9(1):19995. doi: 10.1038/s41598-019-56279-0.

2.

Secretory antibodies to citrullinated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first-degree relatives.

Svärd A, Roos Ljungberg K, Brink M, Martinsson K, Sjöwall C, Rantapää Dahlqvist S, Kastbom A.

Clin Exp Immunol. 2020 Feb;199(2):143-149. doi: 10.1111/cei.13381. Epub 2019 Oct 22.

3.

Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk.

Martinsson K, Roos Ljungberg K, Ziegelasch M, Cedergren J, Eriksson P, Klimovich V, Reckner Å, Griazeva I, Sjöwall C, Samoylovich M, Skogh T, Wetterö J, Kastbom A.

Rheumatology (Oxford). 2019 Aug 27. pii: kez348. doi: 10.1093/rheumatology/kez348. [Epub ahead of print]

PMID:
31504979
4.

Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis.

Roos Ljungberg K, Joshua V, Skogh T, Eklund A, Sköld CM, Karimi R, Nyrén S, Svärd A, Catrina AI, Kastbom A.

Rheumatology (Oxford). 2019 Sep 5. pii: kez377. doi: 10.1093/rheumatology/kez377. [Epub ahead of print]

PMID:
31504962
5.

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Odqvist L, Jevnikar Z, Riise R, Öberg L, Rhedin M, Leonard D, Yrlid L, Jackson S, Mattsson J, Nanda S, Cohen P, Knebel A, Arthur S, Thörn K, Svenungsson E, Jönsen A, Gunnarsson I, Tandre K, Alexsson A, Kastbom A, Rantapää-Dahlqvist S, Eloranta ML, Syvänen AC, Bengtsson A, Johansson P, Sandling JK, Sjöwall C, Rönnblom L, Collins B, Vaarala O.

Ann Rheum Dis. 2019 Oct;78(10):1363-1370. doi: 10.1136/annrheumdis-2019-215434. Epub 2019 Jul 12.

6.

Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.

Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C.

Clin Exp Immunol. 2018 Oct;194(1):27-38. doi: 10.1111/cei.13180. Epub 2018 Sep 12.

7.

Structural Basis of Cross-Reactivity of Anti-Citrullinated Protein Antibodies.

Ge C, Xu B, Liang B, Lönnblom E, Lundström SL, Zubarev RA, Ayoglu B, Nilsson P, Skogh T, Kastbom A, Malmström V, Klareskog L, Toes REM, Rispens T, Dobritzsch D, Holmdahl R.

Arthritis Rheumatol. 2019 Feb;71(2):210-221. doi: 10.1002/art.40698. Epub 2019 Jan 4.

PMID:
30152126
8.

Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.

Kastbom A, Roos Ljungberg K, Ziegelasch M, Wetterö J, Skogh T, Martinsson K.

Clin Exp Immunol. 2018 Dec;194(3):391-399. doi: 10.1111/cei.13206. Epub 2018 Oct 14.

9.

Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.

Ziegelasch M, Forslind K, Skogh T, Riklund K, Kastbom A, Berglin E.

Arthritis Res Ther. 2017 Sep 2;19(1):195. doi: 10.1186/s13075-017-1403-0.

10.

Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage.

Ge C, Tong D, Liang B, Lönnblom E, Schneider N, Hagert C, Viljanen J, Ayoglu B, Stawikowska R, Nilsson P, Fields GB, Skogh T, Kastbom A, Kihlberg J, Burkhardt H, Dobritzsch D, Holmdahl R.

JCI Insight. 2017 Jul 6;2(13). pii: 93688. doi: 10.1172/jci.insight.93688. eCollection 2017 Jul 6.

11.

Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.

Stümer J, Biermann MHC, Knopf J, Magorivska I, Kastbom A, Svärd A, Janko C, Bilyy R, Schett G, Sjöwall C, Herrmann M, Muñoz LE.

Clin Exp Immunol. 2017 Sep;189(3):372-382. doi: 10.1111/cei.12987. Epub 2017 Jun 13.

12.

Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.

Ziegelasch M, van Delft MA, Wallin P, Skogh T, Magro-Checa C, Steup-Beekman GM, Trouw LA, Kastbom A, Sjöwall C.

Arthritis Res Ther. 2016 Dec 3;18(1):289.

14.

Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.

Hellberg S, Eklund D, Gawel DR, Köpsén M, Zhang H, Nestor CE, Kockum I, Olsson T, Skogh T, Kastbom A, Sjöwall C, Vrethem M, Håkansson I, Benson M, Jenmalm MC, Gustafsson M, Ernerudh J.

Cell Rep. 2016 Sep 13;16(11):2928-2939. doi: 10.1016/j.celrep.2016.08.036.

15.

Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking.

Roos K, Martinsson K, Ziegelasch M, Sommarin Y, Svärd A, Skogh T, Kastbom A.

Arthritis Res Ther. 2016 May 23;18(1):119. doi: 10.1186/s13075-016-1014-1.

16.

Differences in sexual behavior, health, and history of child abuse among school students who had and had not engaged in sexual activity by the age of 18 years: a cross-sectional study.

Kastbom ÅA, Sydsjö G, Bladh M, Priebe G, Svedin CG.

Adolesc Health Med Ther. 2016 Jan 8;7:1-11. doi: 10.2147/AHMT.S95493. eCollection 2016.

17.

IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis.

Sandin C, Eriksson P, Segelmark M, Skogh T, Kastbom A.

Clin Exp Immunol. 2016 May;184(2):208-15. doi: 10.1111/cei.12769. Epub 2016 Feb 25.

18.

Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis.

Kastbom A, Ärlestig L, Rantapää-Dahlqvist S.

J Rheumatol. 2015 Oct;42(10):1740-5. doi: 10.3899/jrheum.141529. Epub 2015 Jul 15.

PMID:
26178285
19.

Associations with smoking and shared epitope differ between IgA- and IgG-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis.

Svärd A, Skogh T, Alfredsson L, Ilar A, Klareskog L, Bengtsson C, Kastbom A.

Arthritis Rheumatol. 2015 May;67(8):2032-7. doi: 10.1002/art.39170.

20.

Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity.

Enocsson H, Sjöwall C, Wirestam L, Dahle C, Kastbom A, Rönnelid J, Wetterö J, Skogh T.

J Rheumatol. 2015 May;42(5):817-25. doi: 10.3899/jrheum.140677. Epub 2015 Feb 15.

21.

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van Vollenhoven RF, Lundberg K.

Ann Rheum Dis. 2016 Feb;75(2):356-61. doi: 10.1136/annrheumdis-2014-205698. Epub 2014 Dec 30.

22.

Sexual debut before the age of 14 leads to poorer psychosocial health and risky behaviour in later life.

Kastbom ÅA, Sydsjö G, Bladh M, Priebe G, Svedin CG.

Acta Paediatr. 2015 Jan;104(1):91-100. doi: 10.1111/apa.12803. Epub 2014 Oct 2.

23.

Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.

Enocsson H, Sjöwall C, Kastbom A, Skogh T, Eloranta ML, Rönnblom L, Wetterö J.

Arthritis Rheumatol. 2014 Jun;66(6):1568-73. doi: 10.1002/art.38408.

24.

Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register.

Frodlund M, Dahlström O, Kastbom A, Skogh T, Sjöwall C.

BMJ Open. 2013 Oct 25;3(10):e003608. doi: 10.1136/bmjopen-2013-003608.

25.

Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis.

Kastbom A, Klingberg E, Verma D, Carlsten H, Forsblad-d'Elia H, Wesamaa J, Cedergren J, Eriksson P, Söderkvist P.

Scand J Rheumatol. 2013;42(6):465-8. doi: 10.3109/03009742.2013.779020. Epub 2013 Apr 2.

PMID:
23547871
26.

Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study.

Kastbom A, Cöster L, Arlestig L, Chatzidionysiou A, van Vollenhoven RF, Padyukov L, Rantapää-Dahlqvist S, Saevarsdottir S.

BMJ Open. 2012 Sep 22;2(5). pii: e001524. doi: 10.1136/bmjopen-2012-001524. Print 2012.

27.

Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis.

Svärd A, Kastbom A, Sommarin Y, Skogh T.

Immunobiology. 2013 Feb;218(2):232-7. doi: 10.1016/j.imbio.2012.04.011. Epub 2012 May 4.

PMID:
22652412
28.

IgG rheumatoid factors against the four human Fc-gamma subclasses in early rheumatoid arthritis (the Swedish TIRA project).

Kanmert D, Kastbom A, Almroth G, Skogh T, Enander K, Wetterö J.

Scand J Immunol. 2012 Jan;75(1):115-9. doi: 10.1111/j.1365-3083.2011.02626.x.

29.

A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.

Svärd A, Kastbom A, Söderlin MK, Reckner-Olsson Å, Skogh T.

J Rheumatol. 2011 Jul;38(7):1265-72. doi: 10.3899/jrheum.101086. Epub 2011 Apr 1.

PMID:
21459947
30.

Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome.

Coenen MJ, Enevold C, Barrera P, Schijvenaars MM, Toonen EJ, Scheffer H, Padyukov L, Kastbom A, Klareskog L, Barton A, Kievit W, Rood MJ, Jansen TL, Swinkels D, van Riel PL, Franke B, Bendtzen K, Radstake TR.

PLoS One. 2010 Dec 15;5(12):e14326. doi: 10.1371/journal.pone.0014326.

31.
32.

Designed surface with tunable IgG density as an in vitro model for immune complex mediated stimulation of leukocytes.

Kanmert D, Enocsson H, Wetterö J, Kastbom A, Skogh T, Enander K.

Langmuir. 2010 Mar 2;26(5):3493-7. doi: 10.1021/la9030766.

PMID:
20000861
33.

CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis.

Kastbom A, Johansson M, Verma D, Söderkvist P, Rantapää-Dahlqvist S.

Ann Rheum Dis. 2010 Apr;69(4):723-6. doi: 10.1136/ard.2008.106989. Epub 2009 May 13.

PMID:
19443463
34.

Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project.

Svärd A, Kastbom A, Reckner-Olsson A, Skogh T.

Arthritis Res Ther. 2008;10(4):R75. doi: 10.1186/ar2449. Epub 2008 Jul 4.

35.

Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project).

Kastbom A, Verma D, Eriksson P, Skogh T, Wingren G, Söderkvist P.

Rheumatology (Oxford). 2008 Apr;47(4):415-7. doi: 10.1093/rheumatology/kem372. Epub 2008 Feb 7.

PMID:
18263599
36.

Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis.

Kastbom A, Bratt J, Ernestam S, Lampa J, Padyukov L, Söderkvist P, Skogh T.

Arthritis Rheum. 2007 Feb;56(2):448-52.

37.

The 158V polymorphism of Fc gamma receptor type IIIA in early rheumatoid arthritis: increased susceptibility and severity in male patients (the Swedish TIRA project).

Kastbom A, Ahmadi A, Söderkvist P, Skogh T.

Rheumatology (Oxford). 2005 Oct;44(10):1294-8. Epub 2005 Jul 5.

PMID:
15998631
38.
39.

Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity.

Söderlin MK, Kastbom A, Kautiainen H, Leirisalo-Repo M, Strandberg G, Skogh T.

Scand J Rheumatol. 2004;33(3):185-8.

PMID:
15228190

Supplemental Content

Loading ...
Support Center